Literature DB >> 22349160

Comparative adherence to oxybutynin or tolterodine among older patients.

Angus Thompson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22349160     DOI： 10.1007/s00228-012-1224-7

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  4 in total

1.  A short-term, multicenter, randomized double-blind dose titration study of the efficacy and anticholinergic side effects of transdermal compared to immediate release oral oxybutynin treatment of patients with urge urinary incontinence.

Authors:  G W Davila; C A Daugherty; S W Sanders
Journal:  J Urol       Date:  2001-07       Impact factor: 7.450

2.  Comparative adherence to oxybutynin or tolterodine among older patients.

Authors:  Tara Gomes; David N Juurlink; Muhammad M Mamdani
Journal:  Eur J Clin Pharmacol       Date:  2011-06-28       Impact factor: 2.953

3.  Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder.

Authors:  P Van Kerrebroeck; K Kreder; U Jonas; N Zinner; A Wein
Journal:  Urology       Date:  2001-03       Impact factor: 2.649

4.  Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence. OROS Oxybutynin Study Group.

Authors:  R U Anderson; D Mobley; B Blank; D Saltzstein; J Susset; J S Brown
Journal:  J Urol       Date:  1999-06       Impact factor: 7.450
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.